Purchase this article with an account.
Lindsay A. Rhodes, Carrie Huisingh, John Johnstone, Massimo A. Fazio, Brandon Smith, Lan Wang, Mark Clark, J. Crawford Downs, Cynthia Owsley, Michael J. A. Girard, Jean Martial Mari, Christopher A. Girkin; Peripapillary Choroidal Thickness Variation With Age and Race in Normal Eyes. Invest. Ophthalmol. Vis. Sci. 2015;56(3):1872-1879. doi: https://doi.org/10.1167/iovs.14-16179.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
This study examined the association between peripapillary choroidal thickness (PCT) with age and race in a group of African descent (AD) and European descent (ED) subjects with normal eyes.
Optic nerve head images from enhanced depth imaging spectral-domain optical coherence tomography of 166 normal eyes from 84 subjects of AD and ED were manually delineated to identify the principal surfaces of Bruch's membrane (BM), Bruch's membrane opening (BMO), and anterior sclera (AS). Peripapillary choroidal thickness was measured between BM and AS at increasing distance away from BMO. The mean PCT was compared between AD and ED subjects and generalized estimating equation (GEE) regression analysis was used to examine the association between race and PCT overall, in each quadrant, and by distance from BMO. Models were adjusted for age, BMO area, and axial length in the regression analysis.
Overall, the mean PCT increased from 63.9 μm ± 18.1 at 0 to 250 μm to 170.3 μm ± 56.7 at 1500 to 2000 μm from BMO. Individuals of AD had a greater mean PCT than those of ED at all distances from BMO (P < 0.05 at each distance) and in each quadrant (P < 0.05 in each quadrant). Results from multivariate regression indicate that ED subjects had significantly lower PCT compared to AD overall and in all quadrants and distances from BMO. Increasing age was also significantly associated with a lower PCT in both ED and AD participants.
Peripapillary choroidal thickness varies with race and age, as individuals of AD have a thicker peripapillary choroid than those of ED. (ClinicalTrials.gov number, NCT00221923.)
This PDF is available to Subscribers Only